Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1ANTI-interleukin-23 immunoglobulin G2 (IGG2) human monoclonal antibody----[2] 96, 97 💬
2Denosumab - - immunoglobulin G2 human monoclonal antibody TO rank ligand[1] Denosumab[1] Denosumab 💬 [1] TNFSF11 💬 [8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[1] 274 💬
3Denosumab - immunoglobulin G2 human monoclonal antibody TO rank ligand[1] Denosumab[1] Denosumab 💬 [1] TNFSF11 💬 [8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[1] 274 💬
4Human immunoglobulin G[1] Human immunoglobulin G (Human immunoglobulin G)[1] Globulin, immune 💬 --[3] 14, 50, 63 💬
5Humanized immunoglobulin gamma 1 (IGG1) kappa monoclonal antibody----[1] 46 💬
6Immunoglobulin G----[9] 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
7Immunoglobulin G cleaving cystein protease derived from E. coli----[2] 43, 44 💬
8Immunoglobulin G1, anti (protein nogo A) (human MUS musculus monoclonal heavy----[1] 2 💬
9Immunoglobulin G1, anti (protein nogo A) (human MUS musculus monoclonal heavy chain), disulfide with human MUS musculus monoclonal light chain, dimer----[1] 2 💬
10Immunoglobulin G1, ANTI-(human type I interferon receptor) (human monoclonal MEDI-546 heavy chain), disulfide with human monoclonal MEDI-546-chain, dimer----[1] 49 💬
11Normal human immunoglobulin G----[1] 65 💬